Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tango Therapeutics, Inc. | 240,000 | reported | 01 May 2026 | tx 2+280,000 |
| Kalaris Therapeutics, Inc. | 95,000 | reported | 19 Mar 2026 | tx 2+330,000 |
| iTeos Therapeutics, Inc. | 0 | reported | 29 Aug 2025 | tx 20+713,629−556,504 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | GRANT_AWARD | Tango Therapeutics, Inc. | 40,000 | 0.00 USD | |
| 01 May 2026 | GRANT_AWARD | Tango Therapeutics, Inc. | 240,000 | 0.00 USD | deriv |
| 19 Mar 2026 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 95,000 | 0.00 USD | deriv |
| 03 Nov 2025 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 235,000 | 0.00 USD | deriv |
| 29 Aug 2025 | TENDER | iTeos Therapeutics, Inc. | 89,429 | — | |
| 29 Aug 2025 | OTHER | iTeos Therapeutics, Inc. | 9,063 | — | deriv |
| 29 Aug 2025 | OTHER | iTeos Therapeutics, Inc. | 252,135 | — | deriv |
| 29 Aug 2025 | OTHER | iTeos Therapeutics, Inc. | 8,123 | — | deriv |
| 29 Aug 2025 | OTHER | iTeos Therapeutics, Inc. | 42,388 | — | deriv |
| 29 Aug 2025 | OTHER | iTeos Therapeutics, Inc. | 135,937 | — | deriv |
| 07 Mar 2025 | GRANT_AWARD | iTeos Therapeutics, Inc. | 24,000 | 0.00 USD | |
| 07 Mar 2025 | GRANT_AWARD | iTeos Therapeutics, Inc. | 145,000 | 0.00 USD | deriv |
| 19 Nov 2024 | PURCHASE | iTeos Therapeutics, Inc. | 5,000 | 7.73 USD | first after silence |
| 07 Mar 2024 | GRANT_AWARD | iTeos Therapeutics, Inc. | 163,200 | 0.00 USD | deriv |
| 05 Dec 2023 | GRANT_AWARD | iTeos Therapeutics, Inc. | 41,000 | 0.00 USD | |
| 12 Oct 2023 | PURCHASE | iTeos Therapeutics, Inc. | 5,000 | 8.37 USD | first after silence |
| 09 Mar 2023 | GRANT_AWARD | iTeos Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 11 Mar 2022 | GRANT_AWARD | iTeos Therapeutics, Inc. | 85,000 | 0.00 USD | deriv |
| 27 Dec 2021 | SALE | iTeos Therapeutics, Inc. | 5,000 | 46.45 USD | |
| 11 Oct 2021 | EXERCISE | iTeos Therapeutics, Inc. | 14,429 | 6.16 USD | |
| 11 Oct 2021 | EXERCISE | iTeos Therapeutics, Inc. | 14,429 | 0.00 USD | deriv |
| 24 Jun 2021 | GRANT_AWARD | iTeos Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 16 Jun 2021 | PURCHASE | iTeos Therapeutics, Inc. | 5,000 | 26.09 USD | |
| 01 Mar 2021 | GRANT_AWARD | iTeos Therapeutics, Inc. | 72,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 19 Nov 2024.